Leucine-Rich α2 Glycoprotein as a Predictor of Small Bowel Disease Activity in Crohn' s Disease: A Retrospective Study

LRG is a reliable and non-invasive biomarker for assessing small bowel disease activity in CD, showing superior diagnostic and prognostic performance compared with conventional biomarkers. It may be a valuable adjunct to endoscopic and imaging evaluations in clinical practice.

Publication Details

Journal
JMA Journal
Published
2025-12-10
DOI
https://doi.org/10.31662/jmaj.2025-0355
Primary Topic
Clusterin in disease pathology
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Leucine-Rich α2 Glycoprotein as a Predictor of Small Bowel Disease Activity in Crohn' s Disease: A Retrospective Study

JMA Journal
Clusterin in disease pathology
article

Leucine-Rich α2 Glycoprotein as a Predictor of Small Bowel Disease Activity in Crohn' s Disease: A Retrospective Study

article en

Abstract

LRG is a reliable and non-invasive biomarker for assessing small bowel disease activity in CD, showing superior diagnostic and prognostic performance compared with conventional biomarkers. It may be a valuable adjunct to endoscopic and imaging evaluations in clinical practice.

JMA JournalVol. 9(1)
Openalex Percentile: Top 45%
Clusterin in disease pathology
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Leucine-Rich α2 Glycoprotein as a Predictor of Small Bowel Disease Activity in Crohn' s Disease: A Retrospective Study · JMA Journal (2025) | TGRS Research Map | TGRS